Capital Croissance
Overview
Capital Croissance is a French private equity firm investing in growing SMEs and mid-cap companies. The firm focuses on equity and quasi-equity investments ranging from €1 million to €50 million per transaction, supporting companies in various sectors and stages of development. Capital Croissance is committed to responsible investment practices, emphasizing ethical standards and societal responsibility in its operations.
Investment Focus
- Companies with strong growth potential
- Established businesses seeking expansion
- Entrepreneurial management teams
Portfolio Companies
Reach Capital Croissance directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Capital Croissance
What sectors does Capital Croissance invest in?
Capital Croissance invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Real Estate, and is based in Île-De-France, France. Capital Croissance is listed as a private equity in the ConnectSafely investor database.
What stage does Capital Croissance invest at?
Capital Croissance backs companies at Early Stage, Growth, Late Stage and Buyout, writing cheques of 1M - 50M.
Which regions does Capital Croissance invest in?
Capital Croissance invests across France, Sub-Saharan Africa, Western Europe, North America and Asia-Pacific.
Who are the partners at Capital Croissance?
Team members listed for Capital Croissance include Marine Jouët (Head of Marketing, Client Servicing & Fundraising) and Alizée Possuelos (Director).
What companies has Capital Croissance invested in?
Capital Croissance's portfolio includes SAFE Diets, BIOBank, altima°, HL Trad, Oceanet Technology-NBS, SNADEC, Babyzen and Spas.
How do I contact Capital Croissance?
Capital Croissance's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
